We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Biomarker Panel Could Accelerate Autism Diagnoses

By LabMedica International staff writers
Posted on 17 Sep 2018
Print article
Image: An Agilent 1290 ultra-high performance liquid chromatograph (UHPLC) coupled to an Agilent G6490 Triple Quadrupole Mass Spectrometer (Photo courtesy of Agilent Technologies).
Image: An Agilent 1290 ultra-high performance liquid chromatograph (UHPLC) coupled to an Agilent G6490 Triple Quadrupole Mass Spectrometer (Photo courtesy of Agilent Technologies).
Autism Spectrum Disorder is characterized by core symptoms of altered social communication and repetitive behaviors or circumscribed interests and has a prevalence of 1:59 children in the USA. Affected individuals vary enormously in the severity of their autistic characteristics as well as in the occurrence of many co-morbid conditions.

No biomarker tests for autism spectrum disorder (ASD) currently exist. Children are diagnosed based on their altered behaviors, which may not become evident until children are two to four years old. Families often must wait over a year or more for an appointment with a specialist, delaying diagnosis even further.

A team of scientists working with those at the University of California Davis (Davis, CA, USA) recruited children, ages 18 to 48 months, from eight centers across the USA. Each participant underwent physical, neurological and behavioral examinations. Metadata was obtained about the children's birth, developmental, medical and immunization histories, dietary supplements and medications. Parents’ medical histories were also obtained. Blood was collected from subjects after at least a 12 hour fast by venipuncture into 6 mL sodium heparin tubes on wet ice.

The investigators used the Waters AccQTag Ultra kit, which employs derivatization of amine moieties with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate and was employed for all samples prior to multiple reaction monitoring (MRM) on a liquid chromatography (LC) mass spectrometry (MS) system consisting of an Agilent 1290 ultra-high performance liquid chromatograph (UHPLC) coupled to an Agilent G6490 Triple Quadrupole Mass Spectrometer.

The team compared blood metabolites, specifically, amino acids, in 516 children with ASD and 164 children showing typical development. They found that 17% of the ASD children had unique concentrations of specific amino acids, known as metabotypes, in their blood. Though a 17% subgroup may seem small, it is actually quite significant. The combination of glutamine, glycine, and ornithine Amino Acid Dysregulation Metabotypes (AADMs) identified a dysregulation in amino acid/ branch chain amino acid (AA/BCAA) metabolism that is present in 16.7% of the ASD subjects and is detectable with a specificity of 96.3% and a positive predictive value (PPV) of 93.5%.

The author demonstrates one approach to analyzing the metabolism of ASD to successfully identify reproducible metabotypes. Analysis of the study samples is ongoing and there will be additional metabotypes, which will be diagnostic for subsets of children with ASD. Stratifying ASD based on metabotypes offers an opportunity to identify efficacious interventions within metabotypes that can lead to more precise and individualized treatment.

David G. Amaral, PhD, a professor of psychiatry and lead investigator of the study, said, “With this panel of alterations in amino acid metabolism, we can detect about 17% of kids with ASD. This is the first of hopefully many panels that will identify other subsets of kids with autism.” The study was published on September 6, 2018, in the journal Biological Psychiatry.

Related Links:
University of California Davis

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
LH ELISA
Luteinizing Hormone ELISA
New
Quantitative Immunoassay Analyzer
AS050

Print article

Channels

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more